Diphenoxylate Hydrochloride And Atropine Sulfate Tablet
Product Images NDC 76385-107

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diphenoxylate Hydrochloride And Atropine Sulfate (NDC 76385-107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unichem Pharmaceuticals (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Diphenoxylate 01)

Chemical structure diagram of Diphenoxylate Hydrochloride, showing its molecular formula components and arrangement, including a hydrochloride (HCl) group.*

FDA Label Image

Chemical Structure (Diphenoxylate 02)

Chemical structure diagram of Diphenoxylate Hydrochloride and Atropine Sulfate, showing the molecular arrangement including a bicyclic ring, nitrogen and oxygen atoms, and sulfate hydrate (H2SO4•H2O).*

FDA Label Image

Principal Display Panel (2.5 mg/0.025 mg Tablet Bottle Label)

Label for Diphenoxylate Hydrochloride and Atropine Sulfate Tablets USP 2.5 mg/0.025 mg, showing 100 tablets. The label includes storage instructions (store below 25°C), dosing information, a caution about habit formation, and a special note against use in children under 6 years. It lists Bayshore Pharmaceuticals, LLC as the distributor with a revision date of 01/2019 and displays the product NDC 76385-107-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.